Leukemia mRNA expression profile compared to control spleen
| mRNA . | Leukemia . | |||
|---|---|---|---|---|
| IgHG (AML) (%) . | IgHR (L-ML) (%) . | |||
| + . | − . | + . | − . | |
| MPO | 92 (61 of 66) | 5 (3 of 60) | 21 (8 of 38) | 68 (26 of 38) |
| LysM | 6 (4 of 65) | 26 (17 of 65) | 22 (7 of 32) | 53 (17 of 32) |
| PU1 | 47 (15 of 32) | 6 (4 of 65) | 47 (15 of 32) | 9 (3 of 32) |
| Vpre-B | 0 (0 of 71) | 100 (71 of 71) | 47 (18 of 38) | 53 (20 of 38) |
| CD19 | 0 (0 of 51) | 96 (49 of 51) | 0 (0 of 32) | 75 (24 of 32) |
| Rag1 | 0 (0 of 54) | 100 (0 of 54) | 36 (12 of 33) | 64 (21 of 33) |
| mRNA . | Leukemia . | |||
|---|---|---|---|---|
| IgHG (AML) (%) . | IgHR (L-ML) (%) . | |||
| + . | − . | + . | − . | |
| MPO | 92 (61 of 66) | 5 (3 of 60) | 21 (8 of 38) | 68 (26 of 38) |
| LysM | 6 (4 of 65) | 26 (17 of 65) | 22 (7 of 32) | 53 (17 of 32) |
| PU1 | 47 (15 of 32) | 6 (4 of 65) | 47 (15 of 32) | 9 (3 of 32) |
| Vpre-B | 0 (0 of 71) | 100 (71 of 71) | 47 (18 of 38) | 53 (20 of 38) |
| CD19 | 0 (0 of 51) | 96 (49 of 51) | 0 (0 of 32) | 75 (24 of 32) |
| Rag1 | 0 (0 of 54) | 100 (0 of 54) | 36 (12 of 33) | 64 (21 of 33) |
+, > 2-fold control spleen; −, < 0.5-fold control spleen.